Get started

Swingtrading

Sarla Poly - Low Risk SetupCMP 98.42 on 17.01.25 Since March 2024, the stock has been moving in a parallel channel-like pattern. This time touched the lower edge of the channel and showed a bounceback too. If the momentum continues, it may go to 105/120 or even more depending on the conditions. MACD is showing a likely reversal too. If it sustains below 88, the setup will go weak. This illustration is only for learning and sharing purposes, not buying or selling advice. Please do your research before making any trades. All the best.
NSE:SARLAPOLYLong
by anandlive
Container Corporation of India Ltd (CONCOR) READY TO CONQUERContainer Corporation of India Ltd (CONCOR) provides inland container transportation by rail and manages ports, air cargo complexes, and cold chains. It has a market cap of ₹47,778 Cr. The company is almost debt-free and maintains a healthy dividend payout of 54.9%. Technical Analysis : Respecting its previous low and forming a triple bottom type structure. On the weekly chart, it has formed a bullish harami candlestick pattern in a downtrend, which is a confirmation to go long. With a very small stop loss of 25 point s, one can aim for the target mentioned and trail accordingly.
NSE:CONCORLong
by Vikrant_Mighty
1
Himadri Speciality Chemical Ltd. Himadri Speciality Chemical Ltd. is a leading player in the chemical industry, primarily engaged in the manufacturing of carbon materials and chemicals. Profitability: The company's profitability has been on an upward trajectory, with significant growth in net profit margins and overall financial stability. Technical Analysis: On the technical front, Himadri Speciality Chemical Ltd. is exhibiting a Head and Shoulders pattern on the daily time frame, indicating a potential target of 670++
NSE:HSCLLong
by Vikrant_Mighty
3
BEML- Breakout updateBEML CMP: 4360.25; RSI: 67.40; BEML has completed primary level ABC correction pattern. Now clear breakout above 4280 level was observed as script is sustaining above breakout level from last 3 consecutive trading sessions, representing strength in script and bottoming out signs. Thus, fresh position in BEML can be initiated. Chart structure is strong and must be accumulated for a swing trade as per below suggested levels. Accumulation Zone: 4300-4400 Stop Loss: 4280 Target: 4604-5052-6234 ✅ FOR MORE TRADING IDEAS LIKE THIS, PLEASE LIKE, SHARE, AND FOLLOW MY IDEA STREAM ✅
NSE:BEMLLong
by DrPrashantVerma
INTERGLOBE AVIATION-UP FOR SWING TRADEInterGlobe Aviation: CMP:4469; RSI: 69.62 As per Elliot wave analysis, Inter Globe Aviation has completed primary wave-4 formation @ 3780 and motive wave-5 is in its initial phase of expansion. Confirmation of the same will be evident when script give close above 4885 levels on closing basis. A swing trade is poised in the near future with a upside of 15-20%. Call For Aggressive traders Buy Zone: 4400-4500 Stop Loss: 4300 Resistance Zone: 4772-4885 Target 1: 5125; Target 2: 5400 Call For long term Investor Buy above: 4900 Target: 6400 (1 year time frame) Stop Loss: 4300
NSE:INDIGOLong
by DrPrashantVerma
Stock Analysis: #ZOMATO – The Ride Seems to Have Ended (For Now)Hello, Traders! 👋 #ZOMATO is showing signs of weakness after facing rejection at its all-time high (ATH). Here’s the technical breakdown: 📉 Technical Overview: 🔹 The stock is trading below its long-term 150-day EMA, a bearish signal. 🔹 Critical moving averages are sloping downward, further confirming the negative trend. 🔹 Rejection at ATH suggests the bullish momentum has paused or reversed for the time being. 💡 My View: I was holding this stock, but given the current setup, it seems the ride has ended for now. I’ll be watching for stabilization or signs of a reversal before reconsidering any position. ⚠️ Disclaimer: 🔹 I am not a SEBI-registered advisor. 🔹 This analysis reflects my personal views and is not a recommendation to buy or sell. 🔹 Shared for learning purposes only—please do your own research or consult a professional. What’s your take on #ZOMATO? Let’s discuss! #TradingView #StockAnalysis #MomentumTrading #ZOMATO
NSE:ZOMATOLong
by Inwardlocus
Stock Analysis: #PARAS – Early Potential ReversalHello, Traders! 👋 Let’s talk about #PARAS, a defence sector stock that is showing strong signs of a potential upmove. Here's the breakdown: 📈 Technical Overview: 🔹 The stock has posted its highest quarterly volume for consecutive days, indicating strong accumulation. 🔹 It is trading near a multi-week breakout level on the weekly chart and is well above the last two weeks' highs. 🔹 Momentum in the defence sector aligns well with the stock's setup, enhancing its potential. 💡 My View: My ILTF indicator signaled an entry earlier, but broader market conditions weren’t favorable then, leading to an exit signal later. Now, it looks like #PARAS might turn positive again. Tracking closely for confirmation. ⚠️ Disclaimer: 🔹 I am not a SEBI-registered advisor. 🔹 This analysis reflects my personal views and is not a recommendation to buy or sell. 🔹 Shared for learning purposes only—please do your own research or consult a professional. Are you watching the defence sector momentum? Let’s discuss #PARAS! 🚀 #TradingView #StockAnalysis #DefenceStocks #MomentumTrading #PARAS
NSE:PARAS
by Inwardlocus
Morepen Lab Near Key Support – Big Move Ahead?Morepen Laboratories (NSE: MOREPENLAB) - A Critical Technical Setup In-Depth Chart Analysis 1. Descending Trendline Resistance: • The stock is moving within a descending triangle pattern, with a clear downward trendline acting as resistance since the peak around ₹120. • Currently, the stock is approaching this trendline near ₹80. A breakout above this level, supported by strong volume, could trigger bullish momentum. 2. Key Moving Averages: • 200-Day EMA (Exponential Moving Average): The 200-day EMA is positioned at ₹69.66, which serves as a critical long-term support. The stock has tested this level multiple times, indicating its importance. • The price is hovering slightly above the EMA, suggesting the stock is at a decisive point for trend confirmation. 3. Support Levels: • ₹69.66: Immediate support lies here, aligning with the 200-day EMA. If this level holds, the stock could see a bounce toward higher resistance levels. • ₹65.00 and ₹55.00: If the stock fails to hold ₹69.66, it could slide to ₹65.00, a psychological support, and then to ₹55.00, which marks a previous consolidation zone. 4. Resistance Levels: • ₹80.00: The descending trendline converges with this resistance. A breakout above ₹80.00 could open the path to ₹95.00. • ₹95.00: A crucial horizontal resistance zone. Beyond this, ₹115.00 could be the next major target. 5. Volume Profile: • Recent volume spikes near support levels suggest accumulation by long-term investors. • Watch for increasing volume during any breakout above ₹80.00, which would confirm strong buying interest. 6. Bollinger Bands: • The price is trading near the lower Bollinger Band, indicating oversold conditions. • A rebound toward the middle or upper band could align with a breakout above the ₹80.00 resistance. 7. RSI (Relative Strength Index): • The RSI is nearing the oversold zone, typically a precursor to a potential reversal. 8. Symmetrical Triangle Formation: • The stock’s current price action within a triangle pattern indicates consolidation. A breakout above the upper trendline or a breakdown below the lower support will dictate the next directional move. Possible Scenarios: Bullish Scenario: • A breakout above ₹80.00 with high volume can propel the stock to test ₹95.00 in the short term. • Sustaining above ₹95.00 could lead to a rally toward ₹115.00, marking a significant reversal of the bearish trend. Bearish Scenario: • A breakdown below ₹69.66 would indicate the continuation of the descending triangle, leading to lower levels like ₹65.00 and ₹55.00. • Increased selling pressure or market weakness could exacerbate the downside. About Morepen Laboratories Company Overview: Morepen Laboratories is a pharmaceutical and healthcare company specializing in Active Pharmaceutical Ingredients (APIs), formulations, and diagnostics. With a strong domestic presence and growing exports, the company’s key products include Loratadine (an anti-allergic API) and well-known OTC brands like Burnol and Dr. Morepen. Financial Highlights: • Revenue: The company has demonstrated consistent revenue growth, driven by exports and rising healthcare demand in India. • Margins: Operating margins are moderate, with scope for improvement as exports scale up. • Debt Levels: A low debt-to-equity ratio reflects strong financial stability. • Cash Flow: Positive operating cash flow highlights effective financial management. Growth Drivers: 1. Increasing demand for APIs globally, especially in regulated markets. 2. Expansion into diagnostics and OTC segments, with a focus on high-margin products. 3. Government incentives under the “Make in India” initiative for the pharmaceutical sector. 4. Investment in R&D to create niche formulations and increase market penetration. Conclusion: The stock is at a pivotal technical and fundamental point. A decisive breakout above ₹80.00 could signal the start of a bullish trend, while a breakdown below ₹69.66 might lead to further downside. Disclaimer: This analysis is for educational purposes only and does not constitute financial advice. Please conduct your own research and consult a certified financial advisor before making investment decisions.
NSE:MOREPENLAB
by Veersoni108